News

Finding a conversation about AI at a conference like BIO 2025 is easy. But making those conversations meaningful and asking ...
The CGM is based on magnetohydrodynamic (MHD) technology, which non-invasively samples interstitial fluid, the body fluid ...
According to the government, the passport will eliminate multiple compliance assessments, reducing duplication across the ...
Basel-based BioVersys stands to receive CHF 5 million upfront under the terms of the deal, which could be worth up to CHF 479 ...
The One Big Beautiful Bill (BBB), which passed (PDF) by a 51-50 vote with Vice President JD Vance casting the tie-breaker, ...
AstraZeneca chief executive Pascal Soriot is considering moving the company's stock exchange listing from the UK to the US – ...
The 7th Exosome-Based Therapeutics Development Summit with never-before-seen data, covering the end-to-end from discovery ...
The next frontier in clinical development is modelling feasibility and continuous scenario-planning, even amid changing ...
Touchstone and Rowley highlight why companies like Eli Lilly, Novo Nordisk, and Genentech are choosing to set up shop in ...
At this year’s Veeva R&D and Quality Summit, it was revealed that Novo Nordisk and Veeva have entered into a new partnership ...